Thomas Woiwode is Director of Adverum Biotechnologies, Inc.. Currently has a direct ownership of 18,822 shares of ADVM, which is worth approximately $89,216. The most recent transaction as insider was on Dec 14, 2020, when has been sold 12,783 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.8K
0% 3M change
0% 12M change
Total Value Held $89,216

Thomas Woiwode Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 14 2020
BUY
Other acquisition or disposition
-
12,783 Added 40.45%
18,822 Common Stock

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
ALGS
Aligos Therapeutics, Inc. Healthcare
GRTS
Gritstone bio, Inc. Healthcare
PASG
Passage BIO, Inc. Healthcare
TPST
Tempest Therapeutics, Inc. Healthcare
TW

Thomas Woiwode

Director
Cambridge, MA

Track Institutional and Insider Activities on ADVM

Follow Adverum Biotechnologies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADVM shares.

Notify only if

Insider Trading

Get notified when an Adverum Biotechnologies, Inc. insider buys or sells ADVM shares.

Notify only if

News

Receive news related to Adverum Biotechnologies, Inc.

Track Activities on ADVM